Abstract:Two alternative binding sites of adamantane-type drugs in the influenza A M2 channel have been suggested, one with the drug binding inside the channel pore and the other with four drug molecule S-binding to the C-terminal surface of the transmembrane domain. Recent computational and experimental studies have suggested that the pore binding site is more energetically favorable but the external surface binding site may also exist. Nonetheless, which drug binding site leads to channel inhibition in vivo and how drug-resistant mutations affect these sites are not completely understood. We applied molecular dynamics simulations and potential of mean force calculations to examine the structures and the free energies associated with these putative drug binding sites in an M2-lipid bilayer system. We found that, at biological pH (~7.4), the pore binding site is more thermodynamically favorable than the surface binding site by ~7 kcal/mol and, hence, would lead to more stable drug binding and channel inhibition. This result is in excellent agreement with several recent studies. More importantly, a novel finding of ours is that binding to the channel pore requires overcoming a much higher energy barrier of ~10 kcal/mol than binding to the C-terminal channel surface, indicating that the latter site is more kinetically favorable. Our study is the first computational work that provides both kinetic and thermodynamic energy information on these drug binding sites. Our results provide a theoretical framework to interpret and reconcile existing and often conflicting results regarding these two binding sites, thus helping to expand our understanding of M2-drug binding, and may help guide the design and screening of novel drugs to combat the virus.

Structural and Energetic Analysis of Drug Inhibition of the Influenza A M2 Proton Channel

Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.

Drug inhibition and proton conduction mechanisms of the influenza a M2 proton channel.

Energetic Analysis of the Two Controversial Drug Binding Sites of the M2 Proton Channel in Influenza A Virus.

Mechanism of drug inhibition and drug resistance of influenza A M2 channel

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Free Energy Calculations on the Two Drug Binding Sites in the M2 Proton Channel

Structure and function of the influenza A M2 proton channel.

Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.

Insights from Investigating the Interactions of Adamantane-Based Drugs with the M2 Proton Channel from the H1N1 Swine Virus

Structural Basis for Interactions between Influenza A Virus M2 Proton Channel and Adamantane-Based Antiviral Drugs

Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.

X-Ray Crystal Structure Of The Influenza A M2 Proton Channel S31n Mutant In Two Conformational States: An Open And Shut Case

In Silico Analysis Revealed a Unique Binding but Ineffective Mode of Amantadine to Influenza Virus B M2 Channel

Recent advances in computational studies on influenza a virus M2 proton channel.

X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance

Investigation into Adamantane-Based M2 Inhibitors with FB-QSAR

An effective molecular blocker of ion channel of M2 protein as anti-influenza a drug

Virtual Screening and Molecular Growth Guide the Design of Inhibitors for the Influenza Virus Drug-Resistant Mutant M2-V27A/S31N.

Design and Synthesis of Pinanamine Derivatives As Anti-Influenza A M2 Ion Channel Inhibitors

Heterodimers of Histidine and Amantadine As Inhibitors for Wild Type and Mutant M2 Channels of Influenza A